-+ 0.00%
-+ 0.00%
-+ 0.00%

Anavex Life Sciences withdraws EU marketing authorization application for blarcamesine; EMA CHMP feedback drops chances of a positive opinion

Reuters·03/25/2026 11:29:59

Please log in to view news